ACUTE ISCHEMIC STROKE (AIS)
Clinical trials for ACUTE ISCHEMIC STROKE (AIS) explained in plain language.
Never miss a new study
Get alerted when new ACUTE ISCHEMIC STROKE (AIS) trials appear
Sign up with your email to follow new studies for ACUTE ISCHEMIC STROKE (AIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stroke drug shows promise in early safety trial
Disease control CompletedThis study tested a drug called Edaravone (MCI-186) in 36 people who had an acute ischemic stroke. The goal was to check the drug's safety and how the body processes it. Participants received either Edaravone or a placebo through an IV over 72 hours. The trial was completed, but …
Matched conditions: ACUTE ISCHEMIC STROKE (AIS)
Phase: PHASE2 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Balloon catheters may improve stroke clot removal
Disease control CompletedThis study tested whether using a balloon-guided catheter helps doctors remove blood clots more effectively in people having a stroke. 110 adults with acute ischemic stroke were randomly assigned to receive clot removal with either a balloon-guided or standard catheter. The main …
Matched conditions: ACUTE ISCHEMIC STROKE (AIS)
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug aims to shield brain cells during emergency stroke procedure
Disease control CompletedThis study tested an experimental drug called SCP776 in 120 adults having emergency surgery to remove a blood clot after a severe stroke. The goal was to see if the drug is safe and helps protect the brain from further damage. Participants received either the drug or a placebo, a…
Matched conditions: ACUTE ISCHEMIC STROKE (AIS)
Phase: PHASE2 • Sponsor: Silver Creek Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC